Quality Assurance and Preventing Serious Adverse Events in the Home Hemodialysis Setting

TY - JOUR

T1 - Quality Assurance and Preventing Serious Adverse Events in the Home Hemodialysis Setting

AU - More, Keigan M.

AU - Tennankore, Karthik

N1 - Funding Information: Financial Disclosure: The authors declare that they have no relevant financial interests. Support: K.T. has received investigator-initiated grant support from Astellas, Otsuka, and Baxter. He has conducted consulting work/Advisory Board work for Otsuka, Janssen, Baxter, and AstraZeneca. K.M. has no conflicts to declare. Funding Information: Support: K.T. has received investigator-initiated grant support from Astellas, Otsuka, and Baxter. He has conducted consulting work/Advisory Board work for Otsuka, Janssen, Baxter, and AstraZeneca. K.M. has no conflicts to declare. Publisher Copyright: © 2021 National Kidney Foundation, Inc.

PY - 2021/3

Y1 - 2021/3

UR - http://www.scopus.com/inward/record.url?scp=85118133169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118133169&partnerID=8YFLogxK

U2 - 10.1053/j.ackd.2021.02.007

DO - 10.1053/j.ackd.2021.02.007

M3 - Review article

C2 - 34717864

AN - SCOPUS:85118133169

SN - 1548-5595

VL - 28

SP - 170

EP - 177

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

IS - 2

ER -